These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. At the heart of the fever: Kawasaki disease. McLellan MC; Baker AL Am J Nurs; 2011 Jun; 111(6):57-63. PubMed ID: 21613923 [No Abstract] [Full Text] [Related]
5. Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy. Yoshida S; Sakurai Y; Takeda T; Fukuda K J Investig Allergol Clin Immunol; 2013; 23(1):52-3. PubMed ID: 23653975 [No Abstract] [Full Text] [Related]
6. Non-classical Kawasaki disease in a 2 month old infant. Hartmann I; Weiss K; Bistritzer T; Baram S; Goldman M Isr Med Assoc J; 2006 Aug; 8(8):581-2. PubMed ID: 16958253 [No Abstract] [Full Text] [Related]
8. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease]. Peng Q; Wu Q; Chen CH; Hong H; Zhang LY Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593 [TBL] [Abstract][Full Text] [Related]
9. Kawasaki disease after all. Rodríguez-González M; Gámez-González LB; Garrido-García M; Yamazaki-Nakashimada MA Semin Arthritis Rheum; 2016 Jun; 45(6):e24. PubMed ID: 26639032 [No Abstract] [Full Text] [Related]
10. Efficacy of plasma exchange therapy for Kawasaki disease by cytokine profiling. Kashiwagi Y; Kawashima H; Akamatsu N; Morishima Y; Nishimata S Ther Apher Dial; 2012 Jun; 16(3):281-3. PubMed ID: 22607573 [No Abstract] [Full Text] [Related]
11. Kawasaki disease complicated by cutaneous vasculitis and peripheral gangrene. Gomez-Moyano E; Vera Casaño A; Camacho J; Sanz Trelles A; Crespo-Erchiga V J Am Acad Dermatol; 2011 May; 64(5):e74-5. PubMed ID: 21496687 [No Abstract] [Full Text] [Related]
12. Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation. Pagnini I; Marino A; Simonini G; Cimaz R Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S170. PubMed ID: 22410254 [No Abstract] [Full Text] [Related]
13. Kawasaki disease in Calcutta. Paul DK; Gupta A; Lahiri M Indian Pediatr; 2000 Nov; 37(11):1264-5. PubMed ID: 11086312 [No Abstract] [Full Text] [Related]
14. [Immunoglobulin in suspected Kawasaki disease]. García Soblechero E; Gómez Santos E; Domínguez Quintero ML; González Vila L An Pediatr (Barc); 2010 Sep; 73(3):151-2. PubMed ID: 20605119 [No Abstract] [Full Text] [Related]
15. Marker of T-cell activation is elevated in refractory Kawasaki disease. Suzuki H; Suenaga T; Takeuchi T; Shibuta S; Yoshikawa N Pediatr Int; 2010 Oct; 52(5):785-9. PubMed ID: 20487370 [TBL] [Abstract][Full Text] [Related]
19. Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment. Lee KY; Oh JH; Han JW; Lee JS; Lee BC Eur J Pediatr; 2005 Jul; 164(7):451-2. PubMed ID: 15782294 [No Abstract] [Full Text] [Related]